A$5 billion worth of drugs have gained PBS listing in Australia since 2007
The Labour government in Australia has approved the listing of over A$5 billion ($4.6 billion) worth of new drugs and vaccines since 2007, according to a statement from the country’s Health Minister, Tanya Plibersek, issued over the weekend.
To date in 2012-13, the government has listed 70 new Pharmaceutical Benefits Schedule (PBS) medicines or extensions to existing PBS listed medicines with a total value of over A$780 million over five years.
Just last month, the trade group Medicines Australia launched its 2013 Federal Election document, calling on all sides of politics to fix deficiencies in the PBS and restore confidence in the process that makes new medicines available to patients (The Pharma Letter May 27).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze